Table 4.

Dose-response association between BPDE-induced 9p21 aberration and bladder cancer risk by tertile analysis

n (%)
Adjusted OR (95% CI)*
CasesControls
9p21
    1st Tertile4 (2.0)55 (27.8)Reference
    2nd Tertile76 (37.4)72 (36.4)13.66 (4.66-40.05)
    3rd Tertile123 (60.6)71 (35.9)23.20 (7.98-67.44)
CEP9
    1st Tertile68 (33.8)60 (30.6)Reference
    2nd Tertile64 (31.8)64 (32.7)1.07 (0.64-1.80)
    3rd Tertile69 (34.3)72 (36.7)0.87 (0.53-1.43)
  • * Adjusted by age, gender, ethnicity, and smoking status.